Laboratory characterization of leukemic cell procoagulants

Clinical Chemistry and Laboratory Medicine

Volumn 55, Issue 8, 2017, Pages 1215-1223

  Hudák, Renáta ^a   Debreceni, Ildikó Beke ^a   Deák, Ivett ^a   Szabó, Gabriella Gál ^a   Hevessy, Zsuzsanna ^a   Antal Szalmás, Péter ^a   Osterud, Bjarne ^b   Kappelmayer, János ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

monocytic leukemia; procoagulant activity; thrombin generation; tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; CANCER PROCOAGULANT; PHOSPHATIDYLSERINE; THROMBIN; BLOOD CLOTTING FACTOR;

ARTICLE; BLOOD CLOTTING; COAGULOMETER; CONTROLLED STUDY; FIBRIN FORMATION; FLOW CYTOMETRY; FLUOROMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONOCYTE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; THROMBIN TIME; ACUTE MYELOID LEUKEMIA; BIOSYNTHESIS; CELL LINEAGE; GENE EXPRESSION REGULATION; LABORATORY; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CELL LINE, TUMOR; CELL LINEAGE; CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LABORATORIES; LEUKEMIA, MYELOID, ACUTE; MONOCYTES; PHOSPHATIDYLSERINES; THROMBIN;

EID: 85025106391     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2017-0021     Document Type: Article

References (22)

1. Franchini M. Thromboembolic risk in hematological malignancies. Clin Chem Lab Med 2015;53:1139-47.
2. Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A. Increased risk of venous thromboembolism in patients with acute leukaemia. Br J Cancer 2006;94:200-2.
3. Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun T. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 2009;113:3911-7.
4. Guzman Uribe P, Vargas-Ruiz AG. Thrombosis in leukemia: incidence, causes and practical management. Curr Oncol Rep 2015;17:19.
5. Lejhancova-Tousovska K, Zapletal O, Vytiskova S, Strbackova P, Sterba J. Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin-Frankfurt-Munster (BFM) protocols. Blood Coag Fibrinol 2012;23:144-54.
6. Kwaan HC, Wang J, Boggio LN. Abnormalities in hemostasis in acute promyelocytic leukemia. Hematol Oncol 2002;20:33-41.
7. Gheldof D, Mullier F, Bailly N, Devalet B, Dogne JM, Chatelain B, et al. Microparticles bearing tissue factor: A link between promyelocytic cells and hypercoagulable state. Thromb Res 2014;133:433-39.
8. Nur S, Anwar M, Saleem M, Ahmad PA. Disseminated intravascular coagulation in acute leukaemias at first diagnosis. Eur J Haematol 1995;55:78-82.
9. Dicke C, Amirkhosravi A, Spath B, Jimenez-Alcazar M, Fuchs T, Davila M, et al. Tissue factor-dependent and-independent pathways of systemic coagulation activation in acute myeloid leukemia: A single-center cohort study. Exp Hematol Oncol 2015;4:22.
10. De Stefano V, Sora F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005;3:1985-92.
11. Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988;71:870-75.
12. Lippi G, Franchini M, Guidi GC. Diagnostic approach to inherited bleeding disorders. Clin Chem Lab Med 2007;45:2-12.
13. Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem 2016;62:699-707.
14. Falanga A, Marchetti M, Russo L. The mechanism of cancer-associated thrombosis. Thromb Res 2015;135 (Suppl 1):S8-S11.
15. Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost 2011;9:2251-61.
16. Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 2008;6:1517-24.
17. Chen VM, Hogg PJ. Encryption and decryption of tissue factor. J Thromb Haemost 2013;11:277-84.
18. Kappelmayer J, Bernabei A, Edmunds LH Jr, Edgington TS, Colman RW. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res 1993;72:1075-81.
19. Marchetti M, Diani E, tenCate H, Falanga A. Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography. Haematologica 2012;97:1173-80.
20. Boles JC, Williams JC, Hollingsworth RM, Wang JG, Glover SL, Owens AP 3rd, et al. Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. Thromb Res 2012;129:197-203.
21. Harrison P, Gardiner C. Invisible vesicles swarm within the iceberg. J Thromb Haemost 2012;10:916-8.
22. Brodin E, Appelbom H, Osterud B, Hilden I, Petersen LC, Hansen JB. Regulation of thrombin generation by TFPI in plasma without and with heparin. Transl Res 2009;53:124-31.